ELIZABETH SIMPKINS
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant|Medical CUMBERLAND, MD NPI 1881636751
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant|Medical MD Janssen Biotech, Inc. All categories
General Payments — all program years on this page
$1,782.27
- Category: General Payments
- Program years: PY2021–2024
- Record count: 86
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,399.23 across 70 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,399.23 | 70 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $143.93 | 9 |
| Acerta Pharma LLC | $140.17 | 7 |
| EISAI INC. | $125.76 | 6 |
| Merck Sharp & Dohme Corporation | $120.85 | 6 |
| Gilead Sciences, Inc. | $98.21 | 4 |
| PFIZER INC. | $96.80 | 4 |
| Astellas Pharma US Inc | $96.18 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $79.47 | 4 |
| Incyte Corporation | $60.65 | 3 |
| ARRAY BIOPHARMA INC | $53.98 | 3 |
| Regeneron Healthcare Solutions, Inc. | $52.62 | 2 |
| Celgene Corporation | $48.60 | 3 |
| E.R. Squibb & Sons, L.L.C. | $40.67 | 2 |
| Alexion Pharmaceuticals, Inc. | $35.65 | 2 |
| Daiichi Sankyo Inc. | $28.81 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $24.78 | 1 |
| ABBVIE INC. | $20.63 | 1 |
| MorphoSys, US Inc. | $19.40 | 1 |
| GlaxoSmithKline, LLC. | $17.86 | 1 |
| Deciphera Pharmaceuticals Inc. | $17.69 | 1 |
| TAIHO ONCOLOGY, INC. | $17.24 | 1 |
| Acrotech Biopharma Inc. | $16.37 | 1 |
| AVEO Pharmaceuticals, Inc. | $15.87 | 1 |
| Lilly USA, LLC | $13.87 | 1 |
| Myriad Genetic Laboratories, Inc. | $13.17 | 1 |
By program year
Records — PY2024 (70)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.